|
Market Closed -
Toronto S.E.
12:14:28 21/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.1000 CAD | 0.00% |
|
-4.76% | - |
| 14/08 | Resverlogix Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 26/06 | Resverlogix Corp. - Shareholder/Analyst Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 7.4TCr | - | - | - | - | - |
| 6.47TCr | - | - | - | - | - |
| 2.73TCr | - | - | - | - | - |
| 2.79TCr | - | - | - | - | - |
| 2.6TCr | - | - | - | - | - |
- Stock Market
- Stocks
- RVX Stock
- Charts Resverlogix Corp.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
